ZVSAOTCPharmaceutical PreparationsFiscal year ends December 31
ZyVersa Therapeutics, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 13, 2026
$0.05+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $388.60K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 26, 2024 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Dec 5, 2023 | 1-for-35 reverse | Earlier per-share figures multiplied by 35 |